Complement activation decreases the ability of HIV transmembrane envelope protein to bind to specific antibody.
el Jarrah
F
F
Hidvégi
T
T
Ujhelyi
E
E
Gyapay
G
G
Salavecz
V
V
Origer
J J
JJ
Hollán
S
S
Füst
G
G
D000818:Animals; D003167:Complement Activation; D006168:Guinea Pigs; D015483:HIV Antibodies / Q000276:immunology*; D015700:HIV Envelope Protein gp41 / Q000276:immunology*; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D011994:Recombinant Proteins / Q000276:immunology
D015483:HIV Antibodies; D015700:HIV Envelope Protein gp41; D011994:Recombinant Proteins